We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Guerbet

Offers products in medical imaging - diagnostic imaging, contrast media - contrast agents, MRI imaging, X Ray imaging... read more Featured Products: More products

Download Mobile App




FDA Approves Contrast Agent for Pediatric Patients

By MedImaging International staff writers
Posted on 12 Sep 2017
Print article
The US Food and Drug Administration (FDA) has approved the MRI contrast agent gadoterate meglumine for intravenous use in children younger than two years old, as well as neonates.

The agent is used to visualize abnormal vascularity in the Central Nervous System (CNS), and a disrupted Blood Brain Barrier (BBB), and previously had FDA approval only for children older than two.

The agent Dotarem (gadoterate meglumine) is manufactured by Guerbet (Paris, France). Dotarem is an ionic gadolinium-based and macrocyclic contrast medium, and has been approved for use in 79 countries.

The review by the FDA was based on a study of 51 children aged 23 months and less, including neonates, in nine centers. The results of the study showed that the safety, and PharmacoKinetic (PK) profiles, using a standard dose (0.1 mmol/kg), were similar in the study group to those of adults and children more than two years old. The observed safety profile of Dotarem in the study group was consistent with that reported in older patients.

VP North America at Guerbet, Massimo Carrara, said, "It is critical for Guerbet to help patients and their healthcare providers meet this medical need. We are committed to providing safe and effective contrast media to improve diagnosis of all populations including those who need special care, like young children. In fact, a study published earlier this year in Pediatric Radiology found that 80% of children's hospitals surveyed now use macrocyclic contrast agents."

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Table
Powered Ultrasound Table-Flat Top
Compact C-Arm with FPD
Arcovis DRF-C R21
New
Wireless Handheld Ultrasound System
TE Air

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.